Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.1.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Total revenue
Operating expenses:    
Research and development, net of reimbursements 6,635 7,849
General and administrative 2,962 3,735
Total operating expenses 9,597 11,584
Loss from operations (9,597) (11,584)
Other income:    
Interest income - net 927 547
Total other income 927 547
Net loss $ (8,670) $ (11,037)
Net loss per share of common stock – basic (in Dollars per share) $ (0.31) $ (0.43)
Weighted average shares of common stock outstanding – basic (in Shares) 27,886,486 25,696,623
Revenue    
Revenue:    
Total revenue
Other Revenue    
Revenue:    
Total revenue